Use of fluorescence imaging and indocyanine green during laparoscopic cholecystectomy: Results of an international Delphi survey.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
12 2022
Historique:
received: 05 04 2022
revised: 25 06 2022
accepted: 12 07 2022
entrez: 25 11 2022
pubmed: 26 11 2022
medline: 30 11 2022
Statut: ppublish

Résumé

Published empirical data have increasingly suggested that using near-infrared fluorescence cholangiography during laparoscopic cholecystectomy markedly increases biliary anatomy visualization. The technology is rapidly evolving, and different equipment and doses may be used. We aimed to identify areas of consensus and nonconsensus in the use of incisionless near-infrared fluorescent cholangiography during laparoscopic cholecystectomy. A 2-round Delphi survey was conducted among 28 international experts in minimally invasive surgery and near-infrared fluorescent cholangiography in 2020, during which respondents voted on 62 statements on patient preparation and contraindications (n = 12); on indocyanine green administration (n = 14); on potential advantages and uses of near-infrared fluorescent cholangiography (n = 18); comparing near-infrared fluorescent cholangiography with intraoperative x-ray cholangiography (n = 7); and on potential disadvantages of and required training for near-infrared fluorescent cholangiography (n = 11). Expert consensus strongly supports near-infrared fluorescent cholangiography superiority over white light for the visualization of biliary structures and reduction of laparoscopic cholecystectomy risks. It also offers other advantages like enhancing anatomic visualization in obese patients and those with moderate to severe inflammation. Regarding indocyanine green administration, consensus was reached that dosing should be on a milligrams/kilogram basis, rather than as an absolute dose, and that doses >0.05 mg/kg are necessary. Although there is no consensus on the optimum preoperative timing of indocyanine green injections, the majority of participants consider it important to administer indocyanine green at least 45 minutes before the procedure to decrease the light intensity of the liver. Near-infrared fluorescent cholangiography experts strongly agree on its effectiveness and safety during laparoscopic cholecystectomy and that it should be used routinely, but further research is necessary to establish optimum timing and doses for indocyanine green.

Sections du résumé

BACKGROUND
Published empirical data have increasingly suggested that using near-infrared fluorescence cholangiography during laparoscopic cholecystectomy markedly increases biliary anatomy visualization. The technology is rapidly evolving, and different equipment and doses may be used. We aimed to identify areas of consensus and nonconsensus in the use of incisionless near-infrared fluorescent cholangiography during laparoscopic cholecystectomy.
METHODS
A 2-round Delphi survey was conducted among 28 international experts in minimally invasive surgery and near-infrared fluorescent cholangiography in 2020, during which respondents voted on 62 statements on patient preparation and contraindications (n = 12); on indocyanine green administration (n = 14); on potential advantages and uses of near-infrared fluorescent cholangiography (n = 18); comparing near-infrared fluorescent cholangiography with intraoperative x-ray cholangiography (n = 7); and on potential disadvantages of and required training for near-infrared fluorescent cholangiography (n = 11).
RESULTS
Expert consensus strongly supports near-infrared fluorescent cholangiography superiority over white light for the visualization of biliary structures and reduction of laparoscopic cholecystectomy risks. It also offers other advantages like enhancing anatomic visualization in obese patients and those with moderate to severe inflammation. Regarding indocyanine green administration, consensus was reached that dosing should be on a milligrams/kilogram basis, rather than as an absolute dose, and that doses >0.05 mg/kg are necessary. Although there is no consensus on the optimum preoperative timing of indocyanine green injections, the majority of participants consider it important to administer indocyanine green at least 45 minutes before the procedure to decrease the light intensity of the liver.
CONCLUSION
Near-infrared fluorescent cholangiography experts strongly agree on its effectiveness and safety during laparoscopic cholecystectomy and that it should be used routinely, but further research is necessary to establish optimum timing and doses for indocyanine green.

Identifiants

pubmed: 36427926
pii: S0039-6060(22)00539-6
doi: 10.1016/j.surg.2022.07.012
pii:
doi:

Substances chimiques

Indocyanine Green IX6J1063HV
Coloring Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S21-S28

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Fernando Dip (F)

Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.

Julio Aleman (J)

Hospital Centro Médico, Laparoscopic surgery, Guatemala.

Esther DeBoer (E)

University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Luigi Boni (L)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano, University of Milan, Milan, Italy.

Michael Bouvet (M)

University of California San Diego, San Diego, CA.

Nicholas Buchs (N)

University Hospitals of Geneva, Geneva, Switzerland.

Thomas Carus (T)

Niels-Stensen-Kliniken, Elisabeth-Hospital, Thuine, Germany.

Michele Diana (M)

Research Institute against Digestive Cancer (IRCAD), Strasbourg, France.

Enrique F Elli (EF)

Mayo Clinic, Jacksonville, FL.

Merlijn Hutteman (M)

Leiden University Medical Center, Leiden, the Netherlands.

Takeaki Ishizawa (T)

Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Norihiro Kokudo (N)

National Center for Global Health and Medicine, Tokyo, Japan.

Emanuele Lo Menzo (E)

Cleveland Clinic Florida, Weston, FL.

Kaja Ludwig (K)

Klinikum Suedstadt Rostock, Rostock, Germany.

Edward Phillips (E)

Cedars-Sinai Medical Center, Los Angeles, CA.

Jean Marc Regimbeau (JM)

CHU Amiens-Picardie, Site Sud, Service de Chirurgie Digestive, Amiens, France.

Homero Rodriguez-Zentner (H)

Hospital Punta Pacífica, Panama, Panama.

Mayank Dramani Roy (MD)

Cleveland Clinic Florida, Weston, FL.

Sylke Schneider-Koriath (S)

Klinikum Suedstadt Rostock, Rostock, Germany.

Rutger M Schols (RM)

Maastricht University Medical Center, Maastricht, Netherlands.

Danny Sherwinter (D)

Maimonides Medical Center, Brooklyn, NY.

Conrad Simpfendorfer (C)

Cleveland Clinic Florida, Weston, FL.

Laurent Stassen (L)

Maastricht University Medical Center, Maastricht, Netherlands.

Samuel Szomstein (S)

Cleveland Clinic Florida, Weston, FL.

Alexander Vahrmeijer (A)

Leiden University Medical Center, Leiden, the Netherlands.

Floris P R Verbeek (FPR)

Leiden University Medical Center, Leiden, the Netherlands.

Matthew Walsh (M)

Cleveland Clinic, Cleveland, OH.

Kevin P White (KP)

ScienceRight Research Consulting, London ON, Canada.

Raul J Rosenthal (RJ)

Cleveland Clinic Florida, Weston, FL. Electronic address: rosentr@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH